Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- November 6, 2025…Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $37.0 million, or $.32 per share, in the third quarter of 2025 compared ...

Investing.com -- Moody’s Ratings has downgraded Kronos Acquisition Holdings Inc.’s corporate family rating to Caa1 from B3, citing a 12-month delay and increased capital costs for relocating its ...

Noble Kronos flagship IEMs deliver cutting-edge 9-driver hybrid sound with titanium shells. Are these $4,500 earphones worth the hype and price? Now, before you roll your eyes at the $4,500 price tag ...

Kronos is a HOLD: TiO2 demand should rise, but KRO lacks operating leverage and control over key feedstocks to benefit from upside. KRO faces significant competition from Chinese producers, especially ...

It’s a question Asa Chandler hasn’t stopped asking since he heard his old friend Tony Kronos was missing. The 40-year-old was last seen at his residence in the 1600 block of Eleonora Street in Eagle ...

Kronos' dividend cut and persistent negative free cash flow highlight ongoing financial strain, with no clear catalysts for improvement on the horizon. Dividend yield is now just 2.99%, lagging behind ...

The latest price target for Kronos Bio (NASDAQ:KRON) was reported by Piper Sandler on November 14, 2024. The analyst firm set a price target for $1.00 expecting KRON to rise to within 12 months (a ...

(RTTNews) - Kronos Bio (KRON) has entered into a definitive merger agreement with Concentra Biosciences, LLC, whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common ...

Performances in N.Y.C. Advertisement Supported by The venerable quartet returned to Zankel Hall with a typically eclectic program and a newfound emotional intensity. By Corinna da Fonseca-Wollheim The ...

Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...